Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to: http://www.uab.edu/news/latest/item/3282-uab-researchers-discover-possible-treatment-for-incurable-lung-disease

 

Sign up and swing a hammer!
UAB/Habitat build second house this fall.
Good News Update
Week of June 29, 2015
Acute Idiopathic Pulmonary Fibrosis
IPF May Respond to Autoimmune Therapy
June 2015 Research Spotlight
June 2015 Employee of the Month
Save the Date August 14 2015